Secretory pathways in endothelin synthesis

British Journal of Pharmacology

Volumn 126, Issue 2, 1999, Pages 391-398

  Russell, Fraser D ^a   Davenport, Anthony P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Endothelin; Endothelin converting enzyme; Secretory pathways

Indexed keywords

2 (4 BIPHENYLYL) 1 (1H TETRAZOL 5 YL)ETHYLAMINOMETHYLPHOSPHONIC ACID; 5,6,8,13 TETRAHYDRO 1,6,9,14 TETRAHYDROXY 3 (2 HYDROXYPROPYL) 7 METHOXY 8,13 DIOXOBENZO[A]NAPHTHACENE 2 CARBOXYLIC ACID; BIG ENDOTHELIN 1; CGS 31447; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME INHIBITOR; ENDOTHELIN RECEPTOR; ISOENZYME; MEMBRANE METALLOENDOPEPTIDASE; PD 069185; PD 159790; PHOSPHORAMIDON; SCH 54470; THIORPHAN; UNCLASSIFIED DRUG; WS 75624 A; WS 75624 B; WS 79089 B;

CELL TRANSPORT; DRUG CYTOTOXICITY; DRUG SELECTIVITY; ENZYME LOCALIZATION; HUMAN; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VASCULAR ENDOTHELIUM;

ASPARTIC ENDOPEPTIDASES; BIOLOGICAL TRANSPORT; ENDOTHELINS; ENDOTHELIUM, VASCULAR; METALLOENDOPEPTIDASES;

EID: 0032940038     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702315     Document Type: Review

References (89)

1. Ahlborg, G., Ottosson-Seeberger, A., Hemsén, A. & Lundberg, J.M. (1994). Big ET-1 infusion in man causes renal ET-1 release, renal and splanchnic vasoconstriction, and increased mean arterial blood pressure. Cardiovasc. Res., 28, 1559-1563.
2. Ahn, K., Sisneros, A.M., Herman, S.B., Pan, S.M., Hupe, D., Lee, C., Nikam, S., Cheng, X.-M., Doherty, AM., Schroeder, R.L., Haleen, S.J., Kaw, S., Emoto, N. & Yanagisawa, M. (1998). Novel selective quinazoline inhibitors of endothelin converting enzyme-1. Biochem. Biophys. Res. Commun., 243, 184-190.
3. Bacon, C.R., Gary, N.R.B. & Davenport, A.P. (1996). Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ. Res., 79, 794-801.
4. Barnes, K., Brown, C. & Turner, A.J. (1998). Endothelin-converting enzyme. Ultrstructural localization and its recycling from the cell surface. Hypertension, 31, 3-9.
5. Barnes, K., Shimada, K., Takahashi, M., Tanzawa, K. & Turner, A.J. (1996). Metallopeptidase inhibitors induce an up-regulation of endothelin-converting enzyme levels and its redistribution from the plasma membrane to an intracellular compartment. J. Cell. Sci., 109, 919-928.
6. 2+ in the secretion of von Willebrand factor from human vascular endothelial cells. Biochem. J., 286, 631-635.
7. Cohn, J.N. (1996). Is there a role for endothelin in the natural history of heart failure? Circulation, 94, 604-606.
8. Corder, R., Khan, N. & Harrison, V.J. (1995). A simple method for isolating human endothelin converting enzyme free from contamination by neutral endopeptidase 24.11. Biochem. Biophys. Res. Commun., 207, 355-362.
9. Davenport, A.P., Kuc, R.E. & Mockridge, J.W. (1998b). Endothelin-converting enzyme in the human vasculature: evidence for differential conversion of big endothelin-3 by endothelial and smooth-muscle cells. J. Card. Pharmacol., 31, S1-S3.
10. Davenport, A.P., Kuc, R.E., Plumpton, C., Mockridge, J.W., Barker, P.J. & Huskisson, N.S. (1998a). Endothelin-converting enzyme in human tissues. Histochem. J., 30, 359-374.
11. De Lombaert, S., Ghai, R.D., Jeng, A.Y., Trapani, A.J. & Webb, R.L. (1994). Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme. Biochem. Biophys. Res. Commun., 204, 407-412.
12. De Lombaert, S., Stamford, L.B., Blanchard, L., Tan, J., Hoyer, D., Diefenbacher, C.G., Wei, D.C., Wallace, E.M., Moskal, M.A., Savage, P. & Jeng, A.Y. (1997). Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11. Bioorg. Med. Chem. Lett., 7, 1059-1064.
13. Docherty, J.C., Gunter, H.E., Kuzio, B., Shoemaker, L., Yang, L.J. & Deslauriers, R. (1997). Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: P-31 NMR studies. J. Mol. Cell. Cardiol., 29, 1665-1673.
14. Doi, Y., Ozaka, T., Fukushige, H., Furukawa, H., Yoshizuka, M. & Fujimoto, S. (1996). Increase in number of Weibel-Palade bodies and endothelin-1 release from endothelial cells in the cadmium-treated rat thoracic aorta. Virchows Arch., 428, 367-373.
15. Doi, Y., Ozaka, T., Katsuki, M., Fukushige, H., Toyama, E., Kanazawa, Y., Arashidani, K. & Fujimoto, S. (1995). Histamine release from Weibel-Palade bodies of toad aortas induced by endothlin-1 and sarafotoxin-S6b. Anat. Rec., 242, 374-382.
16. Emeis, J.J., Van Den Eijnden-Schrauwen, Y., Van Den Hoogen, C.M., De Priester, W., Westmuckett, A. & Lupu, F. (1997). An endothelial storage granule for tissue-type plasminogen activator. J Cell. Biol., 139, 245-256.
17. Emoto, N. & Yanagisawa, M. (1995). Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J. Biol. Chem., 270, 15262-15268.
18. Ewenstein, B.M., Warhol, M.J., Handin, R.I. & Pober, J.S. (1987). Comparison of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells. J. Cell. Biol., 104, 1423-1433.
19. Farquhar, M.G. (1985). Progress in unraveling pathways of Golgi traffic. Annu. Rev. Cell. Biol., 1, 447-488.
20. Ferro, C.J , Spratt, J.C., Haynes, W.G. & Webb, D.J. (1998). Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo. Circulation, 97, 2323-2330.
21. Fleming, J.C., Berger, G., Guichard, J., Cramer, E.M. & Wagner, D.D. (1998). The transmembrane domain enhances granular targeting of P-selectin. Eur. J. Cell. Biol., 75, 331-343.
22. Fujimoto, S., Yamamoto, K., Arashidani, K., Hayabuchuchi, I., Yoshizuka, M. & Nomiyama, T. (1982). Endothelial specific granules in the umbilical veins of the postnatal rabbit. Cell. Tissue Res., 227, 509-518.
23. Fuxe, K., Tinner, B., Staines, W., Hemsen, A., Hersh, L. & Lundberg, J.M. (1991). Demonstration and nature of endothelin-3-like immunoreactivity in somatostatin and choline acetyltransferase-immunoreactive nerve-cells of the neostratum of the rat. Neurosc. Lett., 123, 107-111.
24. Fyhrquist, F., Saijonmaa, O., Metsärinne, K., Tikkanen, I., Rosenlöf, K. & Tikkanen, T. (1990). Raised plasma endothelin-1 concentration following cold presser test. Biochem. Biophys. Res. Commun., 169, 217-221.
25. Gui, G., Xu, D., Emoto, N. & Yanagisawa, M. (1993). Intracellular localization of membrane-bound endothelin-converting enzyme from rat lung. J. Cardiovasc. Pharmacol., 22, S53-S56.
26. Gumbiner, B. & Kelly, R.B. (1982). Two distinct intracellular pathways transport secretory and membrane glycoproteins to the surface of pituitary tumor cells. Cell, 28, 51-59.
27. Hamasaki, K., Doi, Y., Sakamoto, Y., Kashimura, M. & Fujimoto, S. (1995). The contraction of small arteries in the perimetrium by presurgical medication with the luteinizing hormone-releasing hormone agonist to patients with leiomyomas: an electron and immunoelectron microscopy. Fukuoka Acta Med., 86, 389-397.
28. Harrison, V.J., Barnes, K., Turner, A.J., Wood, E., Corder, R. & Vane, J.R. (1995). Identification of endothelin 1 and big endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U.S.A., 92, 6344-6348.
29. Harrison, V.J., Corder, R., Änggård, E.E. & Vane, J.R. (1993). Evidence for vesicles that transport endothelin-1 in bovine aortic endothelial cells. J. Cardiovasc. Pharmacol., 22, S57-S60.
30. Hasegawa, H., Hiki, K., Sawamura, T., Aoyama, T., Okamoto, Y., Miwa, S., Shimohama, S., Kimura, J. & Masaki, T. (1998). Purification of a novel endothelin-converting enzyme specific for big endothelin-3. FEBS. Lett., 428, 304-308.
31. Haynes, W.G. (1995). Endothelins as regulators of vascular tone in man. Clin. Sci., 88, 509-517.
32. Haynes, W.G., Ferro, C.E. & Webb, D.J. (1995). Physiologic role of endothelin in maintenance of vascular tone in humans. J. Cardiovasc. Pharmacol., 26, S183-S185.
33. Haynes, W.G. & Webb, D.J. (1994). Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet, 344, 852-854.
34. Hayward, C.P.M., Cramer, E.M., Song, Z., Zheng, S., Fung, R., Massé, J.-M., Stead, R.H. & Podor, T.J. (1998). Studies of multimerin in human endothelial cells. Blood, 91, 1304-1317.
35. Hemsén, A., Ahlborg, G., Ottosson-Seeberger, A. & Lundberg, J.M. (1995). Metabolism of big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21). Reg. Peptides, 55, 287-297.
36. Herman, W.H., Emancipator, S.N., Rhoten, R. L.P. & Simonson, M.S. (1998). Vascular and glomerular expression of endothelin-1 in normal human kidney. Am. J. Physiol., 44, F8-F17.
37. Kelly, R.B. (1985). Pathways of protein secretion in eukaryotes. Science, 230, 25-32.
38. Korth, P., Egidy, G., Parnot, C., Lemoullec, J.-M., Corvol, P. & Pinet. F. (1997). Construction, expression and characterization of a soluble form of human endothelin-converting-enzyme-1. FEBS. Lett., 417, 365-370.
39. Kurihara, H., Yoshizumi, M., Sugiyama, T., Yamaoki, K., Nagai, R., Takaku, F., Satoh, H., Inui, J., Yanagisawa, M., Masaki, T. & Yazaki, Y. (1989). The possible role of endothelin-1 in the pathogenesis of coronary vasospasm. J. Cardiovasc. Pharmacol., 13, S132-S137.
40. Kwan, A.L., Bavbek, M., Jeng, A.Y., Maniara, W., Toyoda, T., Lappe, R.W., Kassell, N.F. & Lee, K.S. (1997). Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage. J. Neurosurg., 87, 281-286.
41. Loesberg, C., Gonsalves, M.D., Zandbergen, J., Willems, C., Van Aken, W.G., Stel, H.V., Van Mourik, J.A. & De Groot, P.G. (1983). The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. Biochim. Biophys. Acta., 763, 160-168.
42. Macarthur, H., Warner, T.D., Wood, E.G., Corder, R. & Vane, J.R. (1994). Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem. Biophys. Res. Commun. 200, 395-400.
43. Maguire, J.J., Johnson, C.M., Mockridge, J.W. & Davenport, A.P. (1997). Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. Br. J. Pharmacol., 122, 1647-1654.
44. Mayadas, T., Wagner, D.D. & Simpson, P.J. (1989). von Willebrand factor biosynthesis and partitioning between constitutive and regulated pathways of secretion after thrombin stimulation. Blood, 73, 706-711.
45. Mcever, R.P., Beckstead, J.H., Moore, K.L., Marshall-Carlson, L. & Bainton, D.F. (1989). GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J. Clin. Invest., 84, 92-99.
46. Mockridge, J.W., Kuc, R.E., Huskisson, N.S., Barker, P.J. & Davenport, A.P. (1998). Characterization of site-directed antisera against endothelin-converting enzymes (ECE-1α and ECE-1β). J. Cardiovasc. Pharmacol., 31, S35-S37.
47. Moldovan, F., Benanni, H., Fiet, J., Cussenot, O., Dumas, J., Darbord, C. & Soliman, H.R. (1996). Establishment of permanent human endothelial-cells achieved by transfection with SV40 large T-antigen that retain typical phenotypical and functional-characteristics. In Vitro Cell. Dev. Biol., 32, 16-23.
48. Opgenorth, T.J., Wu-Wong, J.R. & Shiosaki, K. (1992). Endothelin-converting enzymes. FASEB. J., 6, 2653-2659.
49. Ozaka, T., Doi, Y., Kayashima, K. & Fujimoto, S. (1997). Weibel-Palade bodies as a storage site of calcitonin gene-related peptide and endothelin-1 in blood vessels of the rat carotid body. Anat. Rec., 247, 388-394.
50. Plumpton, C., Ashby, M.J., Kuc, R.E., O'Reilly, G. & Davenport, A.P. (1996). Expression of endothelin peptides and mRNA in the human heart. Clin. Sci., 90, 37-46.
51. Plumpton, C., Haynes, W.G., Webb, D.J. & Davenport, A.P. (1995). Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm. Br. J. Pharmacol., 116, 1821-1828.
52. Rosenberg, J.B., Foster, P.A., Kaufman, R.J., Vokac, E.A., Moussalli, M., Kroner, P.A. & Montgomery, R.R. (1998). Intracellular trafficking of factor VIII to von Willebrand factor storage grranules. J. Clin. Invest., 101, 613-624.
53. Russell, F.D., Coppell, A.L. & Davenport, A.P. (1998a). In vitro enzymatic processing of radiolabelled big ET-1 in human kidney. Biochem. Pharmacol., 55, 697-701.
54. Russell, F.D., Skepper, J.N. & Davenport, A.P. (1998b). Endothelin peptide and converting enzymes in human endothelium. J. Cardiovasc. Pharmacol., 31, S19-S21.
55. Russell, F.D., Skepper, J.N. & Davenport, A.P. (1998c). Human endothelial cell storage granules. A novel intracellular site for isoforms of the endothelin-converting enzyme. Circ. Res., 83, 314-321.
56. Russell, F.D., Skepper, J.N. & Davenport, A.P. (1998d). Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin. J. Cardiovasc. Pharmacol., 31, 424-430.
57. Russell, F.D., Skepper, J.N., Cheng, X.M., Ahn, K. & Davenport, A.P. (1998e). Evidence for an intracellular endothelin converting enzyme in human endothelial cells. Nuanyn Schmiedebergs Arch. Pharmacol., 358, R710.
58. Sakamoto, Y., Doi, Y., Ohsato, K. & Fujimoto, S. (1993). Immunoelectron microscopy on the localization of endothelin in the umbilical vein of perinatal rabbits. Anat. Rec., 237, 482-488.
59. Saleh, D., Furukawa, K., Tsao, M.S., Maghazachi, A., Corrin, B., Yanagisawa, M., Barnes, P.J. & Giaid, A. (1997). Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines. Am. J. Resp. Cell. Mol. Biol., 16, 187-193.
60. Sansom, C.E., Hoang, V.M. & Turner, A.J. (1995). Molecular modeling of the active site of endotehlin-converting enzyme. J. Card. Pharmacol., 26, S75-S77.
61. Schmidt, M., Kröger, B., Jacob, E., Seulberger, H., Subkowski, T., Otter, R., Meyer, T., Schmalzing, G. & Hillen, H. (1994). Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS. Lett., 356, 238-243.
62. Schweizer, A., Valdenaire, O., Nelböck, P., Deuschle, U., Dumas Milne Edwards, J.-B., Stumpf, J.G. & Löffler, B.-M. (1997). Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem. J., 328, 871-877.
63. Shimada, K., Matsushita, Y., Wakabayashi, K., Takahashi, M., Matsubara, A., Iijima, Y. & Tanzawa, K. (1995). Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem. Biophys. Res. Commun., 207, 807-812.
64. Shinmi, O., Kimura, S., Sawamura, T., Sugita, Y., Yoshizawa, T., Uchiyama, Y., Yanagisawa, M., Goto, K., Masaki, T. & Kanazawa, I. (1989). Endothelin-3 is a novel neuropeptide: isolation and sequence determination of endothelin-1 and endothelin-3 in porcine brain. Biochem. Biophys. Res. Commun., 164, 587-593.
65. Sokolovsky, M., Galron, R., Kloog, Y., Bdolah, A., Indig, F.E., Blumberg, S. & Fleminger, G. (1990). Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance. Proc. Natl. Acad. Sci. U.S.A., 87, 4702-4706.
66. Sporn, L.A., Marder, V.J. & Wagner, D.D. (1986). Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell, 46, 185-190.
67. Sporn, L.A., Marder, V.J. & Wagner, D.D. (1989). Differing polarity of the constitutive and regulated pathways for von Willebrand factor in endothelial cells. J. Cell. Biol., 108, 1283-1289.
68. Takahashi, M., Fukuda, K., Shimada, K., Barnes, K., Turner, A.J., Ikeda, M., Koike, H., Yamamoto, Y. & Tanzawa, K. (1995). Localization of rat endothelin-converting enzyme to vascular endothelial cells and some secretory cells. Biochem. J., 311, 657-665.
69. Takahashi, T., Kanda, T., Inoue, M., Sumino, H., Kobayashi, I., Iwamoto, A. & Nagai, R. (1998). Endothelin converting enzyme inhibitor protects development of right ventricular overload and medial thickening of pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension. Life Sci., 63, PL137-PL143.
70. Tonnessen, T., Naess, P.A., Kirkeboen, K.A., Offstad, J., Ilebekk, A. & Christensen, G. (1993). Release of endothelin from the porcine heart after short-term coronary-artery occlusion. Cardiovasc. Res., 27, 1482-1485.
71. Tsukahara, Y., Matsumura, Y., Kuninobu, K., Kojima, T., Takaoka, M. & Morimoto, S. (1993). Phosphoramidon-sensitive endothelin converting enzyme in cultured vascular smooth muscle cells converts big endothelin-3 to endothelin-3. Life Sci., 53, 465-471.
72. Tsurumi, Y., Fujie, K., Nishikawa, M., Kiyoto, S. & Okuhara, M. (1995b). Biological and pharmacological properties of highly selective new endothelin converting enzyme inhibitor WS79089B isolated from Streptosporangium roseum No. 79089. J. Antibiotics, 48, 169-174.
73. Tsurumi, Y., Ueda, H., Hayashi, K., Takase, S., Nishikawa, M., Kiyoto, S. & Okuhara, M. (1995a). WS75624 A and B, new endothelin converting enzyme inhibitors isolated from Saccharothrix sp. No. 75624. J. Antibiotics., 48, 1066-1072.
74. Turner, A.J. (1993). Endothelin-converting enzymes and other families of metallo-endopeptidases. Biochem. Soc. Transactions, 21, 697-701.
75. Turner, A.J. & Murphy, L.J. (1996). Molecular Pharmacology of endothelin converting enzymes. Biochem. Pharmacol., 51, 91-102.
76. Valdenaire, O., Rohrbacher, E. & Mattei, M.-G. (1995). Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J. Biol. Chem., 270, 29794-29798.
77. Vemulapalli, S., Chintala, M., Stamford, A., Watkins, R., Chiu, P., Sybertz, E. & Fawzi, A.B. (1997). Renal effects of SCH 54470: a triple inhibitor of ECE, ACE, and NEP. Cardiovasc. Drug Rev., 15, 260-272.
78. Wagner, D.D., Olmsted, J.B. & Marder, V.J. (1982). Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J. Cell. Biol., 95, 355-360.
79. Wagner, O.F., Christ, G., Wojta, J., Vierhapper, H., Parzer, S., Nowotny, P.J., Schneider, B., Waldhäusl, W. & Binder, B.R. (1992). Polar secretion of endothelin-1 by cultured endothelial cells. J. Biol. Chem., 267, 16066-16068.
80. Wallace, E.M., Moliterni, J.A., Moskal, M.A., Neubert, A.D., Marcopulos, N., Stamford, L.B., Trapani, A.J., Savage, P., Chou, M. & Jeng, A.Y. (1998). Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme. J. Med. Chem., 41, 1513-1523.
81. Waxman, L., Doshi, K.P., Gaul, S.L., Wang, S., Bednar, R.A. & Stern, A.M. (1994). Identification and characterization of endothelin converting activity from EAHY 926 cells: evidence for the physiologically relevant human enzyme. Arch. Biochem. Biophys., 308, 240-253.
82. Weibel, E.R. & Palade, G.E. (1964). New cytoplasmic components in arterial endothelia. J. Cell. Biol., 23, 101-112.
83. Xu, D., Emoto, N., Giaid, A., Slaughter, C., Kaw, S., Dewit, D. & Yanagisawa, M. (1994). ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell, 78, 473-485.
84. Yanagisawa, H., Yanagisawa, M., Kapur, R.P., Richardson, J.A., Williams, S.C., Clouthier, D.E., De Wit, D., Emoto, N. & Hammer, R.E. (1998). Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development, 125,825-836.
85. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. & Masaki, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411-415.
86. Yorimitsu, K., Moroi, K., Inagaki, N., Saito, T., Masuda, Y., Masaki, T., Seino, S. & Kimura, S. (1995). Cloning and sequencing of a human endothelin converting enzyme in renal adenocarcinoma (ACHN) cells producing endothelin-2. Biochem. Biophys. Res. Commun., 208, 721-727.
87. Yoshimoto, S., Ishizaki, Y., Sasaki, T. & Murota, S. (1991). Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke, 22, 378-383.
88. Yoshitomi, Y., Kojima, S., Ogi, M. & Kuramochi, M. (1998). Acute renal failure in accidental hypothermia of cold water immersion. Am. J. Kid. Diseases, 31, 856-859.
89. Yu, J.C.M. & Davenport, A.P. (1995). Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Br. J. Pharmacol., 114, 551-557.